Presenilin-1 Mutations Are a Cause of Primary Lateral Sclerosis-Like Syndrome

Vázquez-Costa, JF; Payá-Montes, M; Martínez-Molina, M; Jaijo, T; Szymanski, J; Mazón, M; Sopena-Novales, P; Consortium, E; Pérez-Tur, J; Sevilla, T; Morte, B; Carmona, R; Perez-Florido, J; Aquino, V; Ortuño, F; Lopez-Lopez, D; Bostelmann, G; Dopazo, J; Pérez-Jurado, LA

Neuroscience & Neuroimaging Research Collection

Journal article

Presenilin-1 Mutations Are a Cause of Primary Lateral Sclerosis-Like Syndrome

Abstract:: Background and PurposePrimary lateral sclerosis (PLS) is a progressive upper motor neuron (UMN) disorder. It is debated whether PLS is part of the amyotrophic lateral sclerosis (ALS) spectrum, or a syndrome encompassing different neurodegenerative diseases. Recently, new diagnostic criteria for PLS have been proposed. We describe four patients of two pedigrees, meeting definite PLS criteria and harboring two different mutations in presenilin 1 (PSEN1).MethodsPatients underwent neurological and neuropsychological examination, MRI, 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), amyloid-related biomarkers, and next-generation sequencing (NGS) testing.ResultsFour patients, aged 25–45 years old, presented with a progressive UMN syndrome meeting clinical criteria of definite PLS. Cognitive symptoms and signs were mild or absent during the first year of the disease but appeared or progressed later in the disease course. Brain MRI showed microbleeds in two siblings, but iron-related hypointensities in the motor cortex were absent. Brain FDG-PET showed variable areas of hypometabolism, including the motor cortex and frontotemporal lobes. Amyloid deposition was confirmed with either cerebrospinal fluid (CSF) or imaging biomarkers. Two heterozygous likely pathogenic mutations in PSEN1 (p.Pro88Leu and p.Leu166Pro) were found in the NGS testing.ConclusionClinically defined PLS is a syndrome encompassing different neurodegenerative diseases. The NGS testing should be part of the diagnostic workup in patients with PLS, at least in those with red flags, such as early-onset, cognitive impairment, and/or family history of neurodegenerative diseases.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Vázquez-Costa, J. F., Payá-Montes, M., Martínez-Molina, M., Jaijo, T., Szymanski, J., Mazón, M., Sopena-Novales, P., Consortium, E., Pérez-Tur, J., Sevilla, T., Morte, B., Carmona, R., Perez-Florido, J., Aquino, V., Ortuño, F., Lopez-Lopez, D., Bostelmann, G., Dopazo, J., & Pérez-Jurado, L. A. (2021). Presenilin-1 Mutations Are a Cause of Primary Lateral Sclerosis-Like Syndrome. Frontiers in Molecular Neuroscience, 14, 721047–721047.

MLA Style

Vázquez-Costa, JF, et al. “Presenilin-1 Mutations Are a Cause of Primary Lateral Sclerosis-Like Syndrome.” Frontiers in Molecular Neuroscience, vol. 14, 2021, pp. 721047–47.

Chicago Style

Vázquez-Costa, JF, M Payá-Montes, M Martínez-Molina, et al. 2021. “Presenilin-1 Mutations Are a Cause of Primary Lateral Sclerosis-Like Syndrome.” Frontiers in Molecular Neuroscience 14: 721047–47.
Print